Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears PEM Technologies' breast compression device:

This article was originally published in Clinica

Executive Summary

PEM Technologies has received 510(k) clearance to market its device for applying controlled compression during scintigraphic breast imaging. The device, which is covered by US and international patents, supports, positions and immobilises the breast during examinations involving injectable agents. The Bethesda, Maryland, company, which has developed PET scanners optimised for breast imaging, says that several investigators have shown that unless breast compression is applied, small early cancers can be missed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel